Therapeutic targets for neuroblastomas

Por Brodeur, Garrett M, lIyer, Radhika, Croucher, Jamie L, Zhuang, Tiangang, Higashi, Mayumi, Kolla, Venkatadri
Publicado no Expert Opin Ther Targets (2014)

Nanoparticle Delivery of an SN38 Conjugate is More Effective Than Irinotecan in a Mouse Model of Neuroblastoma

Por Iyer, Radhika, Croucher, Jamie L., Chorny, Michael, Mangino, Jennifer L., Alferiev, Ivan S., Levy, Robert J., Kolla, Venkatadri, Brodeur, Garrett M.
Publicado no Cancer Lett (2015)

TrkB Inhibition by GNF-4256 Slows Growth and Enhances Chemotherapeutic Efficacy in Neuroblastoma Xenografts

Por Croucher, Jamie L., Iyer, Radhika, Li, Nanxin, Molteni, Valentina, Loren, Jon, Gordon, W. Perry, Tuntland, Tove, Liu, Bo, Brodeur, Garrett M.
Publicado no Cancer Chemother Pharmacol (2014)

Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy

Por Alferiev, Ivan S., Iyer, Radhika, Croucher, Jamie L., Adamo, Richard F., Zhang, Kehan, Mangino, Jennifer L., Kolla, Venkatadri, Fishbein, Ilia, Brodeur, Garrett M., Levy, Robert J., Chorny, Michael
Publicado no Biomaterials (2015)

Entrectinib is a Potent Inhibitor of Trk-Driven Neuroblastomas in a Xenograft Mouse Model

Por Iyer, Radhika, Wehrmann, Lea, Golden, Rebecca L., Naraparaju, Koumudi, Croucher, Jamie L., MacFarland, Suzanne P., Guan, Peng, Kolla, Venkatadri, Wei, Ge, Cam, Nicholas, Li, Gang, Hornby, Zachary, Brodeur, Garrett M.
Publicado no Cancer Lett (2016)